British Pharmaceutical company ‘Shire’ enters into domestic market
On May 27, according to the related industry, Shire Pharmaceutical which is specialized in rare disorder, confirmed entry into the country, and finished recruitment of overseas presidents in Korea.
Shire is known for the development company of 'Elaprase' which is for Hunter syndrome treatment, a...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
